Enovis (ENOV) vs iRadimed (IRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
iRadimed (IRMD) has outperformed Enovis (ENOV) over the past year, gaining 11.7% versus a loss of 45.2%. Over five years, IRMD leads with a +134.2% price change compared with -80.0% for ENOV. iRadimed is the larger company by market cap ($1.10 billion vs $1.01 billion), about 1.1 times the size.
On valuation, Enovis trades at a lower forward P/E (4.9x vs 35.0x for iRadimed). iRadimed pays a dividend yielding 0.90%, while Enovis does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENOV | IRMD |
|---|---|---|
| Share price | $17.43 | $85.88 |
| Market cap | $1.01B | $1.10B |
| 1-day change | -1.02% | +0.48% |
| YTD return | -34.57% | -11.72% |
| 1-year return | -45.15% | +11.72% |
| 5-year return | -79.99% | +134.20% |
| P/E ratio (TTM) | — | 47.71 |
| Forward P/E | 4.85 | 35.01 |
| EPS (TTM) | $-19.23 | $1.80 |
| Dividend yield | 0.00% | 0.90% |
| Annual dividend | $0.00 | $0.77 |
| 52-week high | $34.28 | $107.90 |
| 52-week low | $16.70 | $71.34 |
| Distance from 52-week high | -49.15% | -20.41% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +115.61% | +37.40% |
| Average volume | 1.45M | 125.83K |
| Shares outstanding | 57.67M | 12.79M |
| Employees | 7,802 | 166 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRMD has outperformed ENOV by 56.9 percentage points over the past year.
- The two companies sit in different sectors: Enovis in Healthcare and iRadimed in Health Care.
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Healthcare · Medical Devices · 7,802 employees
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
ENOV vs IRMD FAQ
Which is bigger, Enovis or iRadimed?
iRadimed (IRMD) is larger, with a market capitalization of $1.10B compared with $1.01B for Enovis (ENOV).
Which stock has performed better over the past year, ENOV or IRMD?
IRMD returned +11.72% over the past 12 months, compared with -45.15% for ENOV (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Enovis or iRadimed?
iRadimed pays a dividend yielding 0.90%, while Enovis does not currently pay a regular dividend.
Are Enovis and iRadimed in the same industry?
No. Enovis is in the Healthcare sector, while iRadimed is in Health Care.